New York-based Maxifyz makes hemp-derived CBD products, with full-spectrum tinctures at the center of its wellness-focused line. Its products are grown and manufactured in the United States, kept below 0.3% THC, and supported by independent laboratory testing that checks finished goods for contaminants as well as cannabinoid content. The company also directs 10% of its net profits to wellness and other charities.
Independent Third-Party Laboratory Testing
compliance_program